Beaird Harris Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
Beaird Harris Wealth Management's PFE Position: Q2 2026 in Review
Beaird Harris Wealth Management increased its Pfizer (PFE) stake by 43% in Q2 2026, buying an estimated $43.5K and bringing the position to 5,560 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #182.
Beaird Harris Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $439K in Q2 2025. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Beaird Harris Wealth Management held 5,560 shares of Pfizer worth $134K as of Q2 2026.
- Beaird Harris Wealth Management bought 1,663 Pfizer shares in Q2 2026, an estimated $43.5K.
- Pfizer made up 0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #182 holding.
- Beaird Harris Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Beaird Harris Wealth Management's Pfizer position peaked at $439K in Q2 2025.
- 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.